Compounds > 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone
Page last updated: 2024-08-24

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Experimental Mammary Neoplasms

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tannock, I1

Other Studies

1 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Experimental Mammary Neoplasms

ArticleYear
Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycin.
    Cancer research, 1983, Volume: 43, Issue:5

    Topics: Animals; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Cell Division; Cyclohexenes; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Drug Therapy, Combination; Leukocyte Count; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Oxygen

1983